Array BioPharma Inc.Boulder, CO United States
Company Description
Array BioPharma wants to offer sufferers of cancer, inflammatory, and metabolic diseases a multitude of treatment options. The development-stage company has seven wholly-owned programs in its development pipeline. Candidates include therapies for solid tumors (ARRY-543), arthritis (ARRY-162), breast cancer (ARRY-380), and type 2 diabetes (ARRY-403). Array also out-licenses some drug programs to
| 3200 Walnut St. | Phone: 303-381-6600 | http://www.arraybiopharma.com |
| Boulder, CO 80301 | Fax: 303-386-1390 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Array BioPharma Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 33 executives listed for Array BioPharma Inc.'s Boulder, CO location. | ||
| Chairman | Kyle Lefkoff | |
|---|---|---|
| CEO and Director | Robert Conway | |
| President, Chief Scientific Officer, and Director | Kevin Koch | |
Financials
| Company Type | Public - NASDAQ: ARRY Headquarters |
|---|---|
| Fiscal Year-End | June |
| 2011 Employees | 259 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Array BioPharma Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
